Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations?
- PMID: 28025838
- DOI: 10.1111/bjh.14495
Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations?
Keywords: Hodgkin lymphoma; fluorodeoxyglucose positron emission tomography; response assessment.
Comment in
-
Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? - Response to Adams & Kwee.Br J Haematol. 2018 Apr;181(1):124-125. doi: 10.1111/bjh.14494. Epub 2017 Jan 20. Br J Haematol. 2018. PMID: 28106255 No abstract available.
Comment on
-
Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.Br J Haematol. 2016 Nov;175(4):652-660. doi: 10.1111/bjh.14292. Epub 2016 Aug 19. Br J Haematol. 2016. PMID: 27539369
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
